This Market Brief is intended to provide a snapshot of the gene editing market for 2015-2020. As such, the information provided can be an important market reference aid for understanding the dynamics of this particular market segment.
Gene editing is a type of genetic engineering. Technologies used to accomplish this are Clustered Regularly-Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nucleases (TALEN), Zinc-Finger Nucleases (ZFN), among others.
CRISPR is a disruptive gene editing methodology that has invigorated the genomics market, taking life science research to another level of innovation. With explosive growth, the technology is not only creating opportunities in genetic engineering, but it is fueling growth for enabling technologies such as next-generation sequencing (NGS), PCR, lab automation, microarrays, nucleic acid prep kits, flow cytometry, and high content analysis/imaging, that play key roles in preparation, transfection and cell ID/confirmation.
This report provides information on the total gene editing market including enabling technologies. It measures the market size ($millions) for 2015 and forecasts five-year growth to 2020 in terms of workflow, product type, geography and application. Vendor share is provided for the gene editing segment (i.e. CRISPR, ZFN, TALEN).
Table of Content
|List of Select Products||Market Demand (2015-2020)|
|1. Overall Gene Editing Market|
2. Gene Editing Assays
3. Enabling Technologies